Trial intelligence / Profile preview

Tranexamic acid in elderly patients undergoing combined AVR and CABG surgery

2006-004561-34Phase 4Active

Sponsor
St. Olavs University Hospital
Start
Sep 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of tranexamic acid in aortic valve disease (AVD), coronary arteriosclerosis and postoperative hemorrhage, sponsored by St. Olavs University Hospital. Primary endpoints: Postoperative bleeding, Postoperative hemoglobin loss and 2 more. Started Sep 2006; status: active.

02

Drugs

tranexamic acid
03

Conditions

aortic valve disease (AVD)coronary arteriosclerosispostoperative hemorrhage

Beyond the preview

Go deeper on 2006-004561-34.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004561-34.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call